GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » FCF Yield %

Hanall Biopharma Co (XKRX:009420) FCF Yield % : 1.16 (As of Apr. 28, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Hanall Biopharma Co's Trailing 12-Month Free Cash Flow is ₩20,445 Mil, and Market Cap is ₩1,761,690 Mil. Therefore, Hanall Biopharma Co's FCF Yield % for today is 1.16%.

The historical rank and industry rank for Hanall Biopharma Co's FCF Yield % or its related term are showing as below:

XKRX:009420' s FCF Yield % Range Over the Past 10 Years
Min: -9.76   Med: 0.01   Max: 3.06
Current: 1.16


During the past 13 years, the highest FCF Yield % of Hanall Biopharma Co was 3.06%. The lowest was -9.76%. And the median was 0.01%.

XKRX:009420's FCF Yield % is ranked better than
60.56% of 1080 companies
in the Drug Manufacturers industry
Industry Median: -0.65 vs XKRX:009420: 1.16

Hanall Biopharma Co's FCF Margin % for the quarter that ended in Dec. 2023 was 3.16%.


Hanall Biopharma Co FCF Yield % Historical Data

The historical data trend for Hanall Biopharma Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co FCF Yield % Chart

Hanall Biopharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.66 -0.34 -0.76 1.95 0.91

Hanall Biopharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 2.38 -1.92 4.59 0.18

Competitive Comparison of Hanall Biopharma Co's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Hanall Biopharma Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanall Biopharma Co's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanall Biopharma Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Hanall Biopharma Co's FCF Yield % falls into.



Hanall Biopharma Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Hanall Biopharma Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=20445.253 / 2245704.33
=0.91%

Hanall Biopharma Co's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=1001.33 * 4 / 2245704.33
=0.18%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hanall Biopharma Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Hanall Biopharma Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanall Biopharma Co (XKRX:009420) Business Description

Traded in Other Exchanges
N/A
Address
12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR
Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co (XKRX:009420) Headlines

No Headlines